Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000037

Director sold 3,208 shares at $19.43 ($62,331)

From the SEC's structured data for this filing

Trades in this filing

Krognes Steve E. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-05 Sale : show line 1 in the form −3,208 $19.43 $62,331 142,591 D
Open-market sales · 3,208 sh · avg $19.43 · $62,331
Loading xslF345X05/wk-form4_1704846873.xml…